[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352239-105":59,"doc-detail-352239-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","single-cell-and-spatial-transcriptomics-reveal-p4ha2-mediated-radiotherapy-resistance-mechanisms-in-breast-cancer","Single-cell and spatial transcriptomics reveal P4HA2-mediated radiotherapy resistance mechanisms in breast cancer","","Radiotherapy resistance in breast cancer remains a major clinical challenge, with the key molecular determinants and responsible cellular populations not fully clarified. This study identifies a radiotherapy-resistance gene panel from TCGA-BRCA and GSE120798 using multi-cohort analysis, then characterizes RRhigh epithelial cells via single-cell and spatial transcriptomics. A machine-learning and Mendelian randomization prognostic model (SSRR) stratifies risk, while in vitro validation confirms P4HA2 roles in suppressing stemness and enhancing DNA damage after irradiation.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/single-cell-and-spatial-transcriptomics-reveal-p4ha2-mediated-radiotherapy-resistance-mechanisms-in-breast-cancer/352239/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/single-cell-and-spatial-transcriptomics-reveal-p4ha2-mediated-radiotherapy-resistance-mechanisms-in-breast-cancer/352239.png","ImageObject",300,407,{"name":92,"@type":93},"Jiven","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-19","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",16,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What is the main problem addressed in this study?","Question",{"text":113,"@type":114},"Radiotherapy resistance in breast cancer and the molecular/cellular drivers that sustain it are not fully understood. The study focuses on identifying determinants and defining mechanisms behind resistance.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were radiotherapy-resistance genes and resistant epithelial populations characterized?",{"text":118,"@type":114},"A radiotherapy resistance gene panel was derived from TCGA-BRCA and GSE120798 cohorts, and RRhigh epithelial cells were characterized using single-cell and spatial transcriptomics.",{"name":120,"@type":111,"acceptedAnswer":121},"What role does P4HA2 play according to the findings?",{"text":122,"@type":114},"P4HA2 is a key model gene upregulated across multiple cancers; P4HA2 knockdown suppresses proliferation and invasion and, together with radiotherapy, reduces stemness while enhancing DNA damage.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},352239,1790611373,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":140,"language":141,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":67,"update_tm":145,"read_time":146,"preview_page_count":19,"preview_urls":147},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","Theranostics 2026, Vol. 16, Issue 5 2192  \nIvyspring  \nInternational Publisher  \nTheranostics  \n2026; 16(5): 2192-2220. doi: 10.7150/thno.121257  \nResearch Paper  \nSingle-cell and spatial transcriptomics reveal P4HA2-mediated radiotherapy resistance mechanisms in breast cancer  \nHuimin Li1,2*, Junzhi Liu2*, Yuheng Jiao3*, Fengyu Xu1, Shurui Wang1,4􀀍, Qiang Tang1􀀍  \n1. The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, China.  \n2. Department of Oncology, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, 200433, China.  \n3. Department of Heart failure, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, 200120, China.  \n4. Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing 100730, China.  \n*These authors contributed equally to this work.  \n􀀍 Corresponding authors: [tangqiang678@zju.edu.cn](tangqiang678@zju.edu.cn) (Qiang Tang); [shurui20200101@163.com](shurui20200101@163.com) (Shurui Wang) .  \n© The author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License ([https://creativecommons.org/licenses/by/4.0/](https://creativecommons.org/licenses/by/4.0/)). See [https://ivyspring.com/terms](https://ivyspring.com/terms) for full terms and conditions.  \nReceived: 2025.07.09; Accepted: 2025.11.04; Published: 2026.01.01  \nAbstract  \nBackground: Radiotherapy resistance in breast cancer remains a major clinical challenge. The key molecular determinants and cellular populations driving this resistance are not fully understood.  \nMethods: A radiotherapy resistance (RR) gene panel was identified from TCGA-BRCA and GSE120798 cohorts. Single-cell and spatial transcriptomics characterized RRhigh epithelial cells (RRhighepi). A prognostic model, named SuperPC and StepCox-based Radiotherapy Resistance model (SSRR), was built via machine learning and Mendelian randomization. Functional roles of Prolyl 4-Hydroxylase Subunit Alpha 2 (P4HA2) were validated in vitro.  \nResults: The RR gene panel was upregulated in tumors and enriched for cell cycle pathways. RRhighepi cells exhibited elevated stemness, activated cell cycle and metabolic programs, and enhanced DNA damage repair. RRhighepi represented a developmental origin and communicated with endothelial cells. The SSRR model stratified patients into high-risk groups with poorer survival and distinct therapeutic responses. P4HA2, a key model gene, was upregulated in multiple cancers. P4HA2 knockdown suppressed proliferation, invasion, and colony formation, and synergized with radiotherapy to reduce stemness and enhance DNA damage. WGCNA confirmed co-module membership of P4HA2 and the RR panel.  \nConclusions: This study, through multi-omics analysis, proposes a potential mechanistic model associated with radiotherapy resistance in breast cancer. P4HA2 is a potential therapeutic target that sensitizes breast cancer to radiotherapy. The RR gene panel and SSRR model provide insights into resistance mechanisms and prognostic stratification.  \nKeywords: radiotherapy resistance, scRNA, breast cancer, P4HA2, machine learning  \nIntroduction  \nRadiotherapy resistance in breast cancer remains a critical concern in clinical oncology, both in terms of incidence and evolving epidemiological trends. A population-based study utilizing the Surveillance, Epidemiology, and End Results (SEER) database analyzed 374,993 patients, of whom 154,697 received radiotherapy. With a median follow-up of 8.9 years, 13% of patients developed second primary malignancies. The incidence of secondary cancers was significantly higher in those who underwent radiotherapy, particularly among younger  \nindividuals and those with longer latency periods [1] . Variations in reported incidence across studies maybe attributable to differences in patient cohorts, radiotherapy protocols, and evaluation criteria. A separate investigation involving 1,003 breast cancer patients","cbCaiqP67LuB54Ra","https://ap.wps.com/l/cbCaiqP67LuB54Ra","pdf",27376433,29,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Introduction","[{\"question\":\"What is the main problem addressed in this study?\",\"answer\":\"Radiotherapy resistance in breast cancer and the molecular/cellular drivers that sustain it are not fully understood. The study focuses on identifying determinants and defining mechanisms behind resistance.\"},{\"question\":\"How were radiotherapy-resistance genes and resistant epithelial populations characterized?\",\"answer\":\"A radiotherapy resistance gene panel was derived from TCGA-BRCA and GSE120798 cohorts, and RRhigh epithelial cells were characterized using single-cell and spatial transcriptomics.\"},{\"question\":\"What role does P4HA2 play according to the findings?\",\"answer\":\"P4HA2 is a key model gene upregulated across multiple cancers; P4HA2 knockdown suppresses proliferation and invasion and, together with radiotherapy, reduces stemness while enhancing DNA damage.\"}]","Single-cell and spatial transcriptomics reveal P4HA2-mediated radiotherapy resistance mechanisms in breast cancer | PDF",1790098508,73,[148,152,156,160],{"page_no":8,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6310b0638a0ff4d31f20516b3bee304e.webp",983,1272,{"page_no":14,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/61713bdb1037f9963becc07f83ef2823.webp",982,1270,{"page_no":81,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d2cc43532f743a2cea59fb93638210ec.webp",981,1269,{"page_no":19,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ef19d784dd4079ef25dcd58bb24d8e22.webp",980,1268]